Science Explorer Back to mapMap
Institution · Tosei General Hospital

Most cited papers from Tosei General Hospital

What are the most cited papers from Tosei General Hospital?

The most cited paper from Tosei General Hospital is "Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis" (Luca Richeldi et al., 2014), with 4,731 citations. Next come "Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report" (1,486) and "Idiopathic pulmonary fibrosis" (1,412).

Showing 50 of 61 papers. Every paper with more than 88 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis Luca Richeldi et al. · New England Journal of Medicine Open access 18 May 2014 4,731
2 Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine 14 Jun 2016 1,486
3 Idiopathic pulmonary fibrosis Fernando J. Martínez, Harold R. Collard, Annie Pardo et al. · Nature Reviews Disease Primers Review 19 Oct 2017 1,412
4 Acute Exacerbations of Idiopathic Pulmonary Fibrosis Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine Open access 21 Jun 2007 1,139
5 Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors 8 Jul 2021 1,130
6 Pirfenidone in idiopathic pulmonary fibrosis H. Taniguchi, Masahito Ebina, Yasuhiro Kondoh et al. · European Respiratory Journal Open access 8 Dec 2009 955
7 Pirfenidone in idiopathic pulmonary fibrosis: Figure 1– J. Swigris, D. Fairclough · European Respiratory Journal Open access 31 Aug 2010 800
8 Embryonic karyotype of abortuses in relation to the number of previous miscarriages Mayumi Ogasawara, Koji Aoki, Setsuo Okada et al. · Fertility and Sterility Open access Feb 2000 610
9 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease Enyu Imai et al. · Clinical and Experimental Nephrology 23 Mar 2007 544
10 Acute Exacerbation in Idiopathic Pulmonary Fibrosis Yasuhiro Kondoh, Hiroyuki Taniguchi, Yoshinori Kawabata et al. · CHEST Journal Jun 1993 464
11 Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study Simon L. F. Walsh et al. · The Lancet Respiratory Medicine Open access 11 May 2016 460
12 Computed Tomography Findings in Pathological Usual Interstitial Pneumonia Hiromitsu Sumikawa, Takeshi Johkoh, Thomas Vail Colby et al. · American Journal of Respiratory and Critical Care Medicine Nov 2007 356
13 Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis Osamu Nishiyama, Yasuhiro Kondoh, Tomoki Kimura et al. · Respirology 11 Dec 2007 315
14 Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient Enyu Imai et al. · Clinical and Experimental Nephrology Jun 2007 298
15 Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia Yuichiro Shindo et al. · American Journal of Respiratory and Critical Care Medicine 15 Jul 2013 296
16 Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Sharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh et al. · American Journal of Respiratory and Critical Care Medicine Open access 26 Feb 2011 290
17 Palliative care in interstitial lung disease: living well Michael Kreuter et al. · The Lancet Respiratory Medicine Open access 13 Oct 2017 271
18 A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis Taisei Mushiroda, Sukanya Wattanapokayakit, Atsushi Takahashi et al. · Journal of Medical Genetics Oct 2008 248
19 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · European Respiratory Journal Open access 22 Apr 2010 248
20 A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19 Yohei Doi et al. · Antimicrobial Agents and Chemotherapy Open access 22 Sep 2020 238
21 Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis Motohiro Kimura, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · Respiration 19 Dec 2012 222
22 Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma et al. · European Respiratory Journal 10 Dec 2014 218
23 Quadriceps Weakness Is Related to Exercise Capacity in Idiopathic Pulmonary Fibrosis Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · CHEST Journal Jun 2005 201
24 Acute exacerbations of fibrotic interstitial lung diseases Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown et al. · Respirology Open access 19 Aug 2019 181
25 Acute exacerbation of interstitial pneumonia following surgical lung biopsy Yasuhiro Kondoh, Hiroyuki Taniguchi, Masanori Kitaichi et al. · Respiratory Medicine Open access 5 Apr 2006 173
26 Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Yasuhiro Kondoh, Hiroyuki Taniguchi, T Katsuta et al. · PubMed Jul 2010 169
27 Acute Interstitial Pneumonia: Thin-Section CT Findings in 36 Patients Takeshi Johkoh, Néstor L. Müller, Hiroyuki Taniguchi et al. · Radiology Jun 1999 160
28 Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF) Shigeki Saito, Ala L. Alkhatib, Jay K. Kolls et al. · Journal of Thoracic Disease Open access Sep 2019 158
29 Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis Sakae A. Homma, Arata Azuma, Hiroyuki Taniguchi et al. · Respirology 18 Jan 2012 146
30 Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · Respiratory Medicine Open access 26 Oct 2004 145
31 Erythromycin Reduces the Severity of Bronchial Hyperresponsiveness in Asthma* H Miyatake, Fumio Taki, Hiroyuki Taniguchi et al. · CHEST Journal Mar 1991 144
32 Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis Harold R. Collard, Luca Richeldi, Dong Soon Kim et al. · European Respiratory Journal Open access May 2017 141
33 Japanese guideline for the treatment of idiopathic pulmonary fibrosis Sakae A. Homma et al. · Respiratory Investigation Jul 2018 135
34 Endolymphatic hydrops and blood–labyrinth barrier in Ménière's disease Mitsuhiko Tagaya, Masahiro Yamazaki, Masaaki Teranishi et al. · Acta Oto-Laryngologica 3 Jan 2011 135
35 Adsorptive Granulocyte and Monocyte Apheresis versus Prednisolone in Patients with Corticosteroid-Dependent Moderately Severe Ulcerative Colitis Hiroyuki Hanai, Fumitoshi Watanabe, Masami Yamada et al. · Digestion 2004 131
36 Acute Exacerbation of Chronic Interstitial Pneumonia C. Isabela S. Silva, Néstor L. Müller, Kiminori Fujimoto et al. · Journal of Thoracic Imaging Aug 2007 127
37 A second update on mapping the human genetic architecture of COVID-19 The COVID-19 Host Genetics Initiative et al. · Nature Open access3,885 authors 6 Sep 2023 125
38 Usual Interstitial Pneumonia and Chronic Idiopathic Interstitial Pneumonia: Analysis of CT Appearance in 92 Patients Hiromitsu Sumikawa, Takeshi Johkoh, Kazuya Ichikado et al. · Radiology Oct 2006 124
39 Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality Kiminori Fujimoto, Hiroyuki Taniguchi, Takeshi Johkoh et al. · European Radiology 6 Aug 2011 123
40 A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes Yukihiro Sato, Hiroyuki Sato, K. Naka et al. · Archives of Virology 7 Apr 2011 122
41 JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias Katsushige Ono et al. · Circulation Journal Open access 10 Mar 2022 120
42 Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Michael Kreuter et al. · European Respiratory Journal Open access 14 Feb 2020 119
43 Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment Arata Azuma, Yoshio Taguchi, Takashi Ogura et al. · Respiratory Research Open access 16 Nov 2011 116
44 Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors Jun Fukihara, Koji Sakamoto, Junji Koyama et al. · Clinical Lung Cancer Aug 2019 114
45 Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Kensuke Kataoka, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · CHEST Journal 27 Mar 2015 114
46 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease Yasuhiro Kondoh et al. · Respiratory Investigation Oct 2021 112
47 Noninvasive Ventilation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Toshiki Yokoyama, Yasuhiro Kondoh, Hiroyuki Taniguchi et al. · Internal Medicine Open access 2010 112
48 Home monitoring in interstitial lung diseases Marlies S Wijsenbeek, Catharina C. Moor, Kerri A. Johannson et al. · The Lancet Respiratory Medicine Open access 4 Oct 2022 105
49 The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction Yasushi Numaguchi, Takahito Sone, Kenji Okumura et al. · Circulation 4 Jul 2006 105
50 Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis Luca Richeldi, Vincent Cottin, Kevin R. Flaherty et al. · Respiratory Medicine Open access 28 Apr 2014 105

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.